Notice: Internet Explorer 11 users may encounter issues loading pages throughout the website. Please turn on IE-11’s compatibility mode while we work to resolve the issue.

>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

Truth and Transparency Legislation Receives Record Number of Cosponsors

Monday, July 18, 2011

ASA is proud to announce that 45 members of Congress have cosponsored H.R. 451, "The Healthcare Truth and Transparency Act of 2011."  The current number of cosponsors is five times greater than the number of cosponsors on any previous version of this legislation. The record number of cosponsors is a result of the great lobbying ASA members performed during the Legislative Conference and the solid work of other organizations in the Truth and Transparency Coalition.  

Currently, patients lack information about the wide variety of individuals who work in health care settings, and they are confused by the increasing ambiguity of health care provider-related advertising, marketing and degree titles. In fact, a recent survey found that 44 percent of patients find it difficult to identify who is a licensed physician (M.D. or D.O.) and who is not by reading what services they offer, their title and other licensing materials. This legislation would provide patients more information in this confusing health care marketplace.

 

With the growing national debt and an increased focus by members of both political parties to reduce health care related spending, precious health care dollars are being wasted on poor and uninformed health care choices by consumers. H.R. 451 would significantly advance patient empowerment and prudent expenditure of health care dollars by enhancing information flow to patients and addressing the lack of clarity in health care provider advertisements, marketing and self-identification.

 

Click here  to learn more about the legislation.

 

« Back to Washington Alerts